Topics

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

06:26 EDT 9 Aug 2019 | ecancermedicalscience

Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery. Even when chemotherapy and radiation successfully destroy the bulk of a patient's glioblastoma cells, they...

Original Article: Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

NEXT ARTICLE

More From BioPortfolio on "Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes"

Quick Search

Relevant Topics

Brain Cancer
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...